在全国范围内改善病人获得癌症临床试验的机会。

< ===背景色: 结束 === >

< 新闻简报 >

关于我们的项目

查看我们的Lazarex CARE、IMPACT和Cancer Wellness HUBs项目的摘要，这些项目提供临床试验导航、财政援助、宣传、外展和社区参与。

了解更多

Lazarex 5.44K Recap

Our 7th annual Lazarex 5.44K fundraiser was the best one so far! The most $$$ raised, most people, most teams, most dogs! Check out the event recap and the fun Lazarex 5.44K photos! Many thanks to all who supported this event.

Willis Watson Story Time

Carmen Bogan, author, narrates Willis Watson Is a Wannabe, a book to inspire young children of color to be the next generation of medical professionals. This is part of our advocacy efforts to advance equity & access in cancer care.

LISTEN | LEARN MORE

< 新闻简报 >

Cancer, Covid, a Bone Marrow Transplant & Clinical Trials

Diagnosed with AML, Laura Beth West faced a series of daunting challenges along her journey to be cancer free. After intense treatment with chemo, she went into remission, but discovered that some cancer remnants remained and kept growing, so she went to MD Anderson for additional help. That’s when they offered her the option to participate in a clinical trial.

我们的工作

在Lazarex癌症基金会，我们帮助确定FDA癌症临床试验方案，并报销癌症临床试验治疗的自费旅费。我们与患者建立起挽救生命的联系，为患者带来希望，并为未来的新疗法提供机会。

观看视频

The State of Diversity in Cancer Clinical Trials 2024

The state of diversity in cancer clinical trials today reflects persistent inequities, with minority racial and ethnic groups being underrepresented. Efforts to improve diversity have faced challenges, including low participation rates among African American and Hispanic American individuals. It is crucial for industry sponsors to prioritize diversity and for Congress to extend mandates to all cancer clinical trials to address this issue effectively.